BETA-LACTAM ANTIBIOTIC-INDUCED RELEASE OF FREE ENDOTOXIN - INVITRO COMPARISON OF PENICILLIN-BINDING PROTEIN (PBP) 2-SPECIFIC IMIPENEM AND PBP 3-SPECIFIC CEFTAZIDIME

被引:160
作者
JACKSON, JJ
KROPP, H
机构
[1] Merck Institute for Therapeutic Research, Rahway, NJ
关键词
D O I
10.1093/infdis/165.6.1033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relative effects of two beta-lactam antibiotics, penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime, upon in vitro induction of lipopolysaccharide (LPS) release were investigated against smooth- and rough-LPS mutant isolates of Pseudomonas aeruginosa. Free LPS liberated from both isolates are 10- to 40-fold higher for ceftazidime-exposed cultures than control or imipenem-treated cultures after 4-8 h at 35-degrees-C despite equivalent MICs. Lethalities of filtrates in mice correlated with in vitro endotoxin assay results. Sub-MIC levels of ceftazidime induced filamentation and LPS release without significant bacterial lysis. Amounts released not only matched the quantities achieved at inhibitory concentrations (e.g., 1-, 2-, and 50-times MIC) of ceftazidime but significantly exceeded levels of LPS liberated by exposure to imipenem, less-than-or-equal-to 100 times its MIC. Sub-MIC levels of imipenem released relatively small amounts of free LPS while reducing colony counts approximately 2 logs more than equivalent amounts of ceftazidime after 2 h. Data suggest that ceftazidime-induced filamentation releases larger quantities of bioreactive LPS than nonfilamentous fast-lysing imipenem.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 64 条
[21]  
Galanos C, 1988, Prog Clin Biol Res, V272, P295
[22]   HUMAN PHAGOCYTES HAVE MULTIPLE LIPID-A-BINDING SITES [J].
GOLENBOCK, DT ;
HAMPTON, RY ;
RAETZ, CRH ;
WRIGHT, SD .
INFECTION AND IMMUNITY, 1990, 58 (12) :4069-4075
[23]  
HARADA M, 1987, TOKYO IKA DAIGAKU ZA, V45, P1025
[24]   DIFFERENCES IN TUMOR NECROSIS FACTOR PRODUCTIVE ABILITY AMONG RODENTS [J].
HARANAKA, K ;
SATOMI, N ;
SAKURAI, A .
BRITISH JOURNAL OF CANCER, 1984, 50 (04) :471-478
[25]  
HOPKIN D A B, 1978, Lancet, V2, P1193
[26]  
HOPKIN DAB, 1977, LANCET, V2, P603
[27]   ENDOTOXIN-TOBRAMYCIN ADDITIVE TOXICITY ON RENAL PROXIMAL TUBULAR CELLS IN CULTURE [J].
JOLY, V ;
BERGERON, Y ;
BERGERON, MG ;
CARBON, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :351-357
[28]   IMMUNOBIOLOGICAL ACTIVITIES OF SYNTHETIC LIPID-A ANALOGS WITH LOW ENDOTOXICITY [J].
KOTANI, S ;
TAKADA, H ;
TAKAHASHI, I ;
OGAWA, T ;
TSUJIMOTO, M ;
SHIMAUCHI, H ;
IKEDA, T ;
OKAMURA, H ;
TAMURA, T ;
HARADA, K ;
TANAKA, S ;
SHIBA, T ;
KUSUMOTO, S ;
SHIMAMOTO, T .
INFECTION AND IMMUNITY, 1986, 54 (03) :673-682
[29]   GRAM-NEGATIVE BACTEREMIA .3. REASSESSMENT OF ETIOLOGY, EPIDEMIOLOGY AND ECOLOGY IN 612 PATIENTS [J].
KREGER, BE ;
CRAVEN, DE ;
CARLING, PC ;
MCCABE, WR .
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03) :332-343
[30]  
KROPP H, 1980, ANTIMICROB AGENTS CH, V17, P933